2007
DOI: 10.3345/kjp.2007.50.5.443
|View full text |Cite
|
Sign up to set email alerts
|

Antithrombin-III as an early prognostic factor in children with acute lung injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 21 publications
0
4
0
Order By: Relevance
“…McClintock et al analyzed 50 adults with ALI and reported that plasma protein C levels were lower in non-survivors than in survivors (6). Researches about pediatric patients with ALI/ARDS have been rarely performed though our center previously reported that decreased antithrombin III levels were associated with the risk of death in children with ALI/ARDS (12). …”
Section: Discussionmentioning
confidence: 99%
“…McClintock et al analyzed 50 adults with ALI and reported that plasma protein C levels were lower in non-survivors than in survivors (6). Researches about pediatric patients with ALI/ARDS have been rarely performed though our center previously reported that decreased antithrombin III levels were associated with the risk of death in children with ALI/ARDS (12). …”
Section: Discussionmentioning
confidence: 99%
“…Antithrombin-III, a serine protease inhibitor, inhibits coagulation factors associated with the intrinsic pathway (Factors X, IX, XI, XII) and thrombin (Factor II). Decreased AT-III levels have been associated with increased mortality in PARDS (87). Protein C is a protein activated by the thrombin-thrombomodulin complex on endothelial cells.…”
Section: Biomarkers Of Dysregulated Coagulation and Fibrosismentioning
confidence: 99%
“…Decreased antithrombin III levels are also associated with mortality in pediatric ARDS. 38 Biomarkers of endothelial injury such as thrombomodulin, 39 von Willebrand factor, 40 angiopoietin 2, and soluble receptor for advance glycation end products 41 are also associated with increased mortality and decreased ventilatorfree days in pediatric ARDS. These biomarkers suggest that coagulopathy and endothelial injury are important pathophysiologic features, and they support a biologic plausibility for in situ pulmonary artery thrombosis in pediatric ARDS.…”
Section: In Situ Pulmonary Artery Thrombosismentioning
confidence: 99%